Table 5 Toxicity profile of the matched cohort
Toxicities | Re-irradiation SABR group (N = 20) | Initial SABR group (N = 60) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Grade 1 | Grade 2 | Grade 3 | Grade 4 | Grade 5 | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Grade 5 | |
Acute | ||||||||||
Cough | 1 (5.0%) | 3 (15.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 3 (5.0%) | 2 (3.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Dyspnea | 1 (5.0%) | 3 (15.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (3.3%) | 1 (1.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Chest wall pain | 2 (10.0%) | 1 (5.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Chronic | ||||||||||
Cough | 0 (0.0%) | 1 (5.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (3.3%) | 3 (5.0%) | 1 (1.7%) | 0 (0.0%) | 0 (0.0%) |
Dyspnea | 0 (0.0%) | 0 (0.0%) | 1 (5.0%) | 0 (0.0%) | 0 (0.0%) | 10 (16.7%) | 3 (5.0%) | 2 (3.3%) | 0 (0.0%) | 1 (1.7%) |
Chest wall pain | 0 (0.0%) | 2 (10.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (3.3%) | 5 (8.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |